Macular Degeneration and Macuhealth
As published by the Macular Degeneration Association and EyeTechEye.com
Various parts of our body react to aging in varying ways. If you had an active lifestyle, your joints may wear out. If you injured yourself at an early age, the effects of that injury may worsen with time.
Your sense of sight is no different.
Age-Related Macular Degeneration (AMD) causes cell deterioration within the macula. Because the macula is located near the middle of the retina, AMD affects your central frame of vision. It will affect such processes as reading, writing, driving and even some cognitive functions, like recognizing locations or faces.
Of the three macular pigments, Meso-Zeaxanthin is concentrated at the center of the macula, where vision is sharpest. Zeaxanthin and Lutein are found further off center. Meso-Zeaxanthin has been recognized as a more powerful neutralizer of free radicals and blocks a wider range of damaging blue light.
What is MacuHealth?
MacuHealth has a unique formulation of 10mg of Meso-Zeaxanthin, 10mg of Lutein, and 2mg of Zeaxanthin. Daily dosage is one capsule per day. In fact, recent studies show that Meso-Zeaxanthin is absorbed into the blood serum and macular pigment levels are increased. MacuHealth is the only nutritional supplement available with a significant amount of Meso-Zeaxanthin. Do not be fooled by claims of other supplements purporting to contain Meso-Zeaxanthin. By patent, only MacuHealth contains the Meso-Zeaxanthin needed to afford protection. While not available in stores, it can be purchased from the manufacturer or through our pharmacy.
Additional information:
- A Brighter Tomorrow
- Benefits of Meso-Zeaxanthin
- Dr. Morgan speaks about Macular Health on ABC – Channel 15 in Phoenix
- Targeting AMD with a Critical Carotenoid
- Macular Pigment Response to a Supplement containing Meso-Zeaxanthin, Lutein and Zeaxanthin
- Augmentation of Macular Pigment Following Supplementation with All Three Macular Carotenoids: An Exploratory Study
- In-Office DNA test detects relative risk of progressive AMD
Dr. Morgan talks about Genetic Testing for Macular Degeneration
